Carlson Capital’s Avidity Biosciences RNAM Stock Holding History

Carlson Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,000	Closed	-$2.02M	–	93
2025 Q4	$2.02M	Buy	+28,000	New	+$1.81M	0.72%	12

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Carlson Capital's RNAM Position: Q1 2026 in Review

Carlson Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 28,000 shares — an estimated $2.02M sold.

Carlson Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $2.02M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Carlson Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Carlson Capital sold 28,000 Avidity Biosciences shares in Q1 2026, an estimated $2.02M.
Carlson Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Carlson Capital's Avidity Biosciences position peaked at $2.02M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Carlson Capital's 13F filing for Q1 2026, filed 28 May 2026.